PT89276A - Processo para a preparacao de uma formulacao farmaceutica de libertacao prolongada - Google Patents

Processo para a preparacao de uma formulacao farmaceutica de libertacao prolongada

Info

Publication number
PT89276A
PT89276A PT89276A PT8927688A PT89276A PT 89276 A PT89276 A PT 89276A PT 89276 A PT89276 A PT 89276A PT 8927688 A PT8927688 A PT 8927688A PT 89276 A PT89276 A PT 89276A
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical formula
prolonged liberation
liberation
prolonged
Prior art date
Application number
PT89276A
Other languages
English (en)
Other versions
PT89276B (pt
Inventor
Howard Stevens
Maryvonne Chariot
Francoise Arnold
Gareth Lewis
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of PT89276A publication Critical patent/PT89276A/pt
Publication of PT89276B publication Critical patent/PT89276B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT89276A 1987-12-21 1988-12-20 Processo para a preparacao de uma formulacao farmaceutica de libertacao prolongada constituida por microgranulos revestidos com etilcelulose e eudragit rs (resina acrilica, polimerizado de esteres dos acidos acrilico e metacrilico) PT89276B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8717855A FR2624732B1 (fr) 1987-12-21 1987-12-21 Formulation pharmaceutique a liberation prolongee

Publications (2)

Publication Number Publication Date
PT89276A true PT89276A (pt) 1989-12-29
PT89276B PT89276B (pt) 1993-12-31

Family

ID=9358116

Family Applications (1)

Application Number Title Priority Date Filing Date
PT89276A PT89276B (pt) 1987-12-21 1988-12-20 Processo para a preparacao de uma formulacao farmaceutica de libertacao prolongada constituida por microgranulos revestidos com etilcelulose e eudragit rs (resina acrilica, polimerizado de esteres dos acidos acrilico e metacrilico)

Country Status (23)

Country Link
US (1) US5112621A (pt)
EP (1) EP0322277B1 (pt)
JP (1) JPH082782B2 (pt)
KR (1) KR960009650B1 (pt)
AR (1) AR243378A1 (pt)
AT (1) ATE71837T1 (pt)
AU (1) AU609916B2 (pt)
CA (1) CA1332567C (pt)
DE (1) DE3868037D1 (pt)
DK (1) DK172370B1 (pt)
ES (1) ES2051881T3 (pt)
FI (1) FI97445C (pt)
FR (1) FR2624732B1 (pt)
GR (1) GR3003826T3 (pt)
HU (1) HU199685B (pt)
IE (1) IE60313B1 (pt)
IL (1) IL88736A (pt)
IT (1) IT8723196A0 (pt)
MX (1) MX169322B (pt)
NO (1) NO179357C (pt)
NZ (1) NZ227412A (pt)
PT (1) PT89276B (pt)
ZA (1) ZA889495B (pt)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
EP0452862B1 (en) * 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Spherical seed cores, spherical granules and process for production thereof
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
GB2258613B (en) * 1991-08-12 1996-01-10 Euro Celtique Sa Pharmaceutical diltiazem formulation
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
ATE217789T1 (de) * 1992-06-04 2002-06-15 Smithkline Beecham Corp Angenehm schmeckende pharmazeutische zusammensetzungen
US5837277A (en) * 1992-06-04 1998-11-17 Smithkline Beecham Corporation Palatable pharmaceutical compositions
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
JP3264722B2 (ja) * 1993-02-25 2002-03-11 第一製薬株式会社 カプセル製剤
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2742660B1 (fr) 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US6245351B1 (en) * 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
EP1009387B1 (en) 1997-07-02 2006-04-12 Euro-Celtique S.A. Stabilized sustained release tramadol formulations
ATE464900T1 (de) * 1998-03-26 2010-05-15 Astellas Pharma Inc Retardpräparat mit makroliden wie tacrolimus
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
UA67802C2 (uk) 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
US6663896B1 (en) 2001-08-01 2003-12-16 Alvin S. Blum Delayed release aspirin for vascular obstruction prophylaxis
KR100407519B1 (ko) * 2001-08-31 2003-12-18 부광약품 주식회사 건조황산제일철과 방출조절제로서 엘-글루타민을 함유하는서방성 정제 및 그의 제조방법
KR100446818B1 (ko) * 2001-11-06 2004-09-01 김재윤 질산 이소소르비드 서방성 펠렛 제형
CN1874767A (zh) 2003-10-29 2006-12-06 惠氏公司 包含aplindore和其衍生物的缓释药物组合物
EP1730516A1 (en) * 2004-03-30 2006-12-13 Pfizer Products Incorporated Method and device for evaluation of pharmaceutical compositions
KR100775957B1 (ko) * 2006-02-07 2007-11-13 경상대학교산학협력단 애기장대 유래의 개화시기를 조절 단백질 ｃｏ의 돌연변이단백질, 상기 단백질을 이용한 식물의 개화시기 조절전사인자의 분리방법 및 식물의 개화시기 조절방법
CN100442981C (zh) * 2006-11-09 2008-12-17 广东省昆虫研究所 一种德国小蠊毒饵
US20100062073A1 (en) * 2006-11-29 2010-03-11 Ronald Arthur Beyerinck Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein
WO2008125940A2 (en) * 2007-04-17 2008-10-23 Pfizer Products Inc. Nanoparticles comprising non-crystalline drug
WO2008135852A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Pharmaceutical compositions comprising nanoparticles and casein
US8309129B2 (en) * 2007-05-03 2012-11-13 Bend Research, Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
US8974827B2 (en) * 2007-06-04 2015-03-10 Bend Research, Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
WO2009010842A2 (en) * 2007-07-13 2009-01-22 Pfizer Products Inc. Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
WO2009073216A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
WO2009073215A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
EP2550863A1 (de) * 2011-07-27 2013-01-30 Bayer Intellectual Property GmbH Aktivstoffhaltige Partikel auf Polyacrylat-Basis
RS57497B1 (sr) 2013-03-14 2018-10-31 Alkermes Pharma Ireland Ltd Prolekovi fumarata i njihova upotreba u lečenju raznih bolesti
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
KR101639163B1 (ko) * 2015-07-08 2016-07-22 울산대학교 산학협력단 저전송 영상 정보 및 센싱 정보 송수신 장치 및 이의 동작 방법
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4533674A (en) * 1983-10-24 1985-08-06 Basf Wyandotte Corporation Process for preparing a sugar and starch free spray-dried vitamin C powder containing 90 percent ascorbic acid
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
JPH0625055B2 (ja) * 1985-03-18 1994-04-06 日本ケミフア株式会社 持続性錠剤
JPS625915A (ja) * 1985-07-03 1987-01-12 Nippon Iyakuhin Kogyo Kk 塩酸ジルチアゼム徐放性製剤及びその製法
US4775536A (en) * 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions

Also Published As

Publication number Publication date
FI97445C (fi) 1996-12-27
IL88736A0 (en) 1989-07-31
HU199685B (en) 1990-03-28
DK708088D0 (da) 1988-12-20
US5112621A (en) 1992-05-12
AR243378A1 (es) 1993-08-31
NO179357B (no) 1996-06-17
NO179357C (no) 1996-09-25
EP0322277B1 (fr) 1992-01-22
DK172370B1 (da) 1998-04-27
FR2624732B1 (fr) 1991-02-15
GR3003826T3 (pt) 1993-03-16
DE3868037D1 (de) 1992-03-05
FR2624732A1 (fr) 1989-06-23
HUT49290A (en) 1989-09-28
FI885884A0 (fi) 1988-12-20
NO885641L (no) 1989-06-22
EP0322277A1 (fr) 1989-06-28
IE883810L (en) 1989-06-21
JPH082782B2 (ja) 1996-01-17
ZA889495B (en) 1989-09-27
NZ227412A (en) 1989-12-21
JPH02202A (ja) 1990-01-05
KR890009380A (ko) 1989-08-01
IE60313B1 (en) 1994-06-29
CA1332567C (en) 1994-10-18
PT89276B (pt) 1993-12-31
AU2707788A (en) 1989-06-22
DK708088A (da) 1989-06-29
FI97445B (fi) 1996-09-13
ES2051881T3 (es) 1994-07-01
MX169322B (es) 1993-06-29
AU609916B2 (en) 1991-05-09
IL88736A (en) 1992-11-15
FI885884A (fi) 1989-06-22
ATE71837T1 (de) 1992-02-15
IT8723196A0 (it) 1987-12-23
NO885641D0 (no) 1988-12-20
KR960009650B1 (en) 1996-07-23

Similar Documents

Publication Publication Date Title
PT89276A (pt) Processo para a preparacao de uma formulacao farmaceutica de libertacao prolongada
PT83756B (pt) Processo para a preparacao de composicoes farmaceuticas com libertacao controlada
PT88099A (pt) Processo para a preparacao de composicoes farmaceuticas de acetaminofeno orais e de libertacao prolongada
BR8805820A (pt) Processo para a preparacao de uma composicao polimerica
PT91731A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ciclosporinas
PT88261A (pt) Processo para a preparacao de nucleosidos com efeito terapeutico
PT93452A (pt) Processo para a preparacao de uma pastilha de colestiramina
BR8803596A (pt) Processo para a preparacao de uma poliolefina
BR8702527A (pt) Processo para a preparacao de uma triazol-sulfonamida
PT83508B (pt) Processo para a preparacao de composicoes farmaceuticas de accao prolongada
PT88037A (pt) Processo para a preparacao de novos compostos tendo uma estrutura comun de pirrole
BR8802484A (pt) Processo para a preparacao de isocianatos
PT89264A (pt) Processo para a preparacao de compostos azabiciclicos
PT87190A (pt) Processo para a preparacao de composicoes farmaceuticas para a reducao dos efeitos indesejaveis das beta-lactaminas
PT88225A (pt) Processo para a preparacao de formulacoes farmaceuticas contendo di-hidropiridinas
PT89075A (pt) Processo para a preparacao de diacidos diarilestiril-quinolinicos
BR8801269A (pt) Processo para a preparacao de um composto de ciano-imidazol
PT90888A (pt) Processo para a preparacao de composicoes farmaceuticas contendo prostaglandinas
PT90435A (pt) Processo aperfeicoado para a preparacao de uma cetimina
PT88181A (pt) Processo para a preparacao de derivados aralquilaminoalcoxifenilo
BR8800430A (pt) Processo para a preparacao de uma composicao termoplastica
PT89039A (pt) Processo para a preparacao de l-ramnose
BR8803678A (pt) Processo para a preparacao de polieteramidas
PT89056A (pt) Processo para a preparacao de hidroxilaminas substituidas
BR8804071A (pt) Processo para a preparacao de compostos de oxo-acil-hidrazida antioxidantes

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19930621

PC3A Transfer or assignment

Free format text: 20000717 SANOFI-SYNTHELABO FR

PD3A Change of proprietorship

Free format text: SANOFI-AVENTIS FR

Effective date: 20050113

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20081220